SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

The community is intensely debating a potential upcoming SpaceX IPO, with widespread skepticism regarding valuations and fears that retail investors are being positioned as exit liquidity for a massive pump-and-dump scheme. While some traders are actively scouting for alternative "proxy" stocks in the aerospace and satellite sectors to capture sector-wide momentum, others are deeply concerned about the sustainability of current space-tech valuations and the impact of extreme hype on market stability.

noice

NOICE is trending as traders speculate on its potential for volatility and explosive growth, fueled by its status as a nanocap meme token and recent appearances on trending gainers lists. The community is actively debating its technical setup, sharing hopes for further exchange visibility, and discussing broader market sentiment regarding altcoin season and upcoming regulatory developments.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant is currently trending due to its pivotal role in institutional pilot projects, including tokenized deposit initiatives with major global banks. The community is heavily focused on its extremely low supply and perceived utility as essential infrastructure for real-world asset tokenization.

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

United Therapeutics Corp

United Therapeutics is experiencing significant market activity driven by positive Phase 3 data for Tyvaso in idiopathic pulmonary fibrosis, which analysts view as a major expansion of its addressable patient population. The community is actively debating the company's long-term competitive positioning against rival inhaled therapies and potential acquisition rumors within the broader respiratory and organ manufacturing sectors.

Glass House Brands, Inc. operates as an integrated cannabis company in the United States with focus on the California market and building brands to serve consumers across various segments. The company is involved in greenhouse cultivation operations, manufacturing practices, brand-building, and retailing activities. The company offers its cannabis products through its portfolio of brands, which includes Glass House Farms, PLUS Products, Allswell, Forbidden Flowers, and Mama Sue Wellness. The company was founded by Kyle Kazan, Graham Farrar and Jocelyn Rosenwald in 2015 and is headquartered in Long Beach, CA.

Glass House Brands Inc - Ordinary Shares (sub voting)

Glass House Brands

Glass House Brands is facing intense community scrutiny regarding potential labor and regulatory issues following reports of recent enforcement actions at cultivation facilities. While some investors remain optimistic about the company's long-term production scale and competitive cost structure in the California market, others are increasingly concerned about operational stability and the potential impact on future growth.

iShares Trust - iShares J.P. Morgan USD Emerging Markets Bond ETF

iShares J.P. Morgan USD Emerging Markets Bond ETF

EMB is trending as traders closely watch emerging market sovereign bond performance amid broader fixed income momentum shifts and cooling inflationary pressure. The community is actively discussing the ETFs role as a diversification tool for income generation, with heightened focus on its price action relative to U.S. Treasuries and potential spread carry opportunities.

Fox Corp. engages in providing television production and broadcasting services. It also provides news under the brands FOX News Media, FOX Sports, FOX Entertainment and FOX Television Stations, and Tubi Media Group. It operates through the following segments: Cable Network Programming, Television, and Other and Corporate. The Cable Network Programming segment refers to the production and licensing of news and sports content distributed primarily through traditional cable television systems, direct broadcast satellite operators, and telecommunication companies and online multi-channel video programming distributors. The Television segment focuses on the acquisition, marketing, and distribution of broadcast network programming. The Other and Corporate segment relates to the FOX Studio Lot, Credible Labs Inc, corporate overhead costs, and intracompany eliminations. The company was founded by Keith Rupert Murdoch on May 3, 2018, and is headquartered in New York, NY.

Fox Corporation - Ordinary Shares - Class B

Fox Corporation - Class B

Fox Corporation is seeing heightened discussion as shareholders navigate the company's evolving programming strategy and leadership changes following recent high-profile defamation settlements. Investors are closely monitoring its performance against media peers while community sentiment remains divided over its editorial direction and competitive position in the streaming landscape.

Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes biopharma, healthcare, education and government, as well as advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The company operates through the Laboratory Solutions segment and Bioscience Production. The Laboratory Solutions segment focuses on research, diagnostic, and quality control workflows. The Bioscience Production segment focuses on high-purity materials for bioprocessing and medical technologies. Avantor was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.

Avantor Inc.

Avantor is gaining traction as investors speculate on potential M&A activity and leadership changes, with sentiment increasingly shifting toward a 'proof-over-potential' approach after mixed financial results. The community is closely watching insider buying trends and the impact of activist involvement on the company's long-term valuation.

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Neogenomics Inc.

Neogenomics is trending as investors react to a string of positive analyst upgrades and strong earnings results, which have reinforced confidence in its oncology testing platform and expanded market opportunities. The community is actively discussing the stock's potential for further re-rating, with many focusing on raised guidance, the launch of new cancer-tracking tests, and the possibility of the company becoming an attractive acquisition target.

What is DAG? In more traditional blockchains, the host provides the food/drinks (i.e resources) for this party. And when the guests arrive, the amount of resources can only accommodate so many people, the portions are small and then everything eventually runs out and the party ends. Think Constellation DAG like a potluck (a party where everyone brings food/drinks). With every added guest (node to the network), the more resources the party has to keep going. This is the nature of Constellation, a distributed system that scales horizontally.  Is Constellation a Blockchain? Not exactly. Although inspired by the principles of decentralization, many standard blockchains such as Bitcoin and Ethereum face scalability issues. This is why the next, generation of decentralized networks such as Hashgraph, IOTA, and Constellation have turned to DAG.  What is a Microservice? “Microservices” is an approach to application development in which a large application is built as a suite of modular services. Each module supports a specific business goal and uses a simple, well-defined interface to communicate with other sets of services. Uber, for example, is not a singular app purse. It is a unified app which means it is a single interface that brings together their driver app, their rider app, and their corporate team app.

Constellation

Constellation (DAG) is trending as traders speculate on the potential enterprise and market impact of the upcoming Nasdaq listing of AI Holdings (AIAI), which acquired Constellation Network assets. The community is focused on the project's pivot toward institutional data infrastructure, defense-grade validation, and the broader convergence of blockchain with AI commercialization.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oculis Holding AG (OCS) Reports Q1 Loss, Lags Revenue Estimates

Oculis Holding AG (OCS) delivered earnings and revenue surprises of -27.71% and -17.08%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Insmed (INSM) Reports Q1 Loss, Misses Revenue Estimates

Insmed (INSM) delivered earnings and revenue surprises of +15.86% and -0.70%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

TG Therapeutics (TGTX) Q1 Earnings Lag Estimates

TG Therapeutics (TGTX) delivered earnings and revenue surprises of -26.88% and +2.81%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Oculis (OCS) to Release Earnings on Monday

Oculis (NASDAQ:OCS) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-oculis-holding-ag-stock...

Gildi lifeyrissjodur Makes New Investment in Oculis Holding AG $OCS

Gildi lifeyrissjodur acquired a new stake in shares of Oculis Holding AG (NASDAQ:OCS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,447,985 shares of the company...

Oculis (NASDAQ:OCS) Sees Strong Trading Volume - What's Next?

Oculis (NASDAQ:OCS) Sees Strong Trading Volume - Should You Buy...

Oculis (NASDAQ:OCS) Sees Unusually-High Trading Volume - What's Next?

Oculis Holding AG (NASDAQ:OCS) Given Consensus Rating of "Moderate Buy" by Brokerages

Oculis Holding AG (NASDAQ:OCS - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight brokerages that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation and seven have issued a buy recomme...

HC Wainwright Reiterates Buy Rating for Oculis (NASDAQ:OCS)

HC Wainwright reiterated a "buy" rating and issued a $44.00 target price on shares of Oculis in a research note on Monday...

Aberdeen Group plc Raises Holdings in Oculis Holding AG $OCS

Aberdeen Group plc boosted its position in Oculis Holding AG (NASDAQ:OCS - Free Report) by 39.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund...

Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The firm's pipeline includes multiple product candidates in development such as, OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for dry eye disease, and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company was founded in 2016 and is headquartered in Zug, Switzerland.

OCS
Oculis Holding AG

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest OCS News

OCSOculis Holding AG